标题
From bench to almost bedside: the long road to a licensed Ebola virus vaccine
作者
关键词
-
出版物
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 18, Issue 2, Pages 159-173
出版商
Informa UK Limited
发表日期
2017-11-17
DOI
10.1080/14712598.2018.1404572
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
- (2017) Ana Maria Henao-Restrepo et al. LANCET
- Chimpanzee Adenovirus Vector Ebola Vaccine
- (2017) Julie E. Ledgerwood et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
- (2017) Jason A. Regules et al. NEW ENGLAND JOURNAL OF MEDICINE
- Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges
- (2016) Stephen B Kennedy et al. Clinical Trials
- Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines
- (2016) Iain D. Milligan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- An Adenovirus Vaccine Expressing Ebola Virus Variant Makona Glycoprotein Is Efficacious in Guinea Pigs and Nonhuman Primates
- (2016) Shipo Wu et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study
- (2016) Olga De Santis et al. LANCET INFECTIOUS DISEASES
- Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
- (2016) Selidji T. Agnandji et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
- (2016) Katie Ewer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Progression of Ebola Therapeutics During the 2014–2015 Outbreak
- (2016) Emelissa J. Mendoza et al. TRENDS IN MOLECULAR MEDICINE
- Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection
- (2016) Andrea Marzi et al. Scientific Reports
- Selecting the Right Tool For the Job
- (2015) Arthur L. Caplan et al. AMERICAN JOURNAL OF BIOETHICS
- Immunology and evolvement of the adenovirus prime, MVA boost Ebola virus vaccine
- (2015) Yan Zhou et al. CURRENT OPINION IN IMMUNOLOGY
- Risk communication in times of crisis: Pitfalls and challenges in ensuring preparedness instead of hysterics
- (2015) G.-F. Bo l EMBO REPORTS
- As Ebola Epidemic Begins to Slow, Trials of Drugs and Vaccines Speed Up
- (2015) Bridget M. Kuehn JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Emergency Postexposure Vaccination With Vesicular Stomatitis Virus–Vectored Ebola Vaccine After Needlestick
- (2015) Lilin Lai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Adenovirus-Vectored Vaccine Provides Postexposure Protection to Ebola Virus–Infected Nonhuman Primates
- (2015) Gary Wong et al. JOURNAL OF INFECTIOUS DISEASES
- Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection: Table 1.
- (2015) Thomas W. Geisbert et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial
- (2015) Hannah Kibuuka et al. LANCET
- Ebola vaccine trials back on track
- (2015) Dara Mohammadi LANCET
- Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial
- (2015) Feng-Cai Zhu et al. LANCET
- Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
- (2015) Ana Maria Henao-Restrepo et al. LANCET
- Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases
- (2015) Claire M Tully et al. LANCET INFECTIOUS DISEASES
- Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus
- (2015) Chad E. Mire et al. NATURE
- High hopes for Guinean vaccine trial
- (2015) M. Enserink SCIENCE
- An Ebola whole-virus vaccine is protective in nonhuman primates
- (2015) A. Marzi et al. SCIENCE
- VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain
- (2015) A. Marzi et al. SCIENCE
- A race for an Ebola vaccine: promises and obstacles
- (2015) Christopher L. Cooper et al. TRENDS IN MICROBIOLOGY
- Transmission of Ebola Viruses: What We Know and What We Do Not Know: Table 1
- (2015) Michael T. Osterholm et al. mBio
- The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola
- (2015) BMJ-British Medical Journal
- Ebola vaccine to be tested on 30 000 volunteers
- (2015) A. Gulland BMJ-British Medical Journal
- The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola
- (2015) BMJ-British Medical Journal
- Ebola vaccine to be tested on 30 000 volunteers
- (2015) A. Gulland BMJ-British Medical Journal
- Neurovirulence and Immunogenicity of Attenuated Recombinant Vesicular Stomatitis Viruses in Nonhuman Primates
- (2014) D. K. Clarke et al. JOURNAL OF VIROLOGY
- Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial
- (2014) Iman Satti et al. LANCET INFECTIOUS DISEASES
- Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial
- (2014) Joost H C M Kreijtz et al. LANCET INFECTIOUS DISEASES
- A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola Infection
- (2014) Jin Huk Choi et al. MOLECULAR PHARMACEUTICS
- Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
- (2014) Xiangguo Qiu et al. NATURE
- Ebola experts seek to expand testing
- (2014) Declan Butler NATURE
- Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge
- (2014) Daphne A Stanley et al. NATURE MEDICINE
- Emergence of Zaire Ebola Virus Disease in Guinea
- (2014) Sylvain Baize et al. NEW ENGLAND JOURNAL OF MEDICINE
- Durability of a Vesicular Stomatitis Virus-Based Marburg Virus Vaccine in Nonhuman Primates
- (2014) Chad E. Mire et al. PLoS One
- Vaccinating captive chimpanzees to save wild chimpanzees
- (2014) K. L. Warfield et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents
- (2014) Gary Wong et al. VACCINE
- Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Protects Nonhuman Primates from Intramuscular and Aerosol Challenge with Ebolavirus
- (2013) A. S. Herbert et al. JOURNAL OF VIROLOGY
- Airway Delivery of an Adenovirus-Based Ebola Virus Vaccine Bypasses Existing Immunity to Homologous Adenovirus in Nonhuman Primates
- (2013) J. S. Richardson et al. JOURNAL OF VIROLOGY
- Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates
- (2013) A. Marzi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pathogenesis of Venezuelan equine encephalitis
- (2013) Katherine G. Taylor et al. VETERINARY MICROBIOLOGY
- Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine
- (2013) Joseph E. Blaney et al. PLoS Pathogens
- Animal models for Ebola and Marburg virus infections
- (2013) Eri Nakayama et al. Frontiers in Microbiology
- Nomenclature for Immune Correlates of Protection After Vaccination
- (2012) S. A. Plotkin et al. CLINICAL INFECTIOUS DISEASES
- A strategy to simultaneously eradicate the natural reservoirs of rabies and Ebola virus
- (2012) Gary Wong et al. Expert Review of Vaccines
- Cutaneous manifestations of filovirus infections
- (2012) Dieudonné Nkoghe et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Safety, Immunogenicity, and Surrogate Markers of Clinical Efficacy for Modified Vaccinia Ankara as a Smallpox Vaccine in HIV-Infected Subjects
- (2012) R. N. Greenberg et al. JOURNAL OF INFECTIOUS DISEASES
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Rafael Lozano et al. LANCET
- Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination
- (2012) Cheng Cheng et al. PLoS One
- Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques
- (2012) G. G. Olinger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Successful Treatment of Ebola Virus-Infected Cynomolgus Macaques with Monoclonal Antibodies
- (2012) X. Qiu et al. Science Translational Medicine
- Immune Parameters Correlate with Protection Against Ebola Virus Infection in Rodents and Nonhuman Primates
- (2012) G. Wong et al. Science Translational Medicine
- Eliminating Rabies in Estonia
- (2012) Florence Cliquet et al. PLoS Neglected Tropical Diseases
- Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates
- (2012) Chad E. Mire et al. PLoS Neglected Tropical Diseases
- Management of Accidental Exposure to Ebola Virus in the Biosafety Level 4 Laboratory, Hamburg, Germany
- (2011) Stephan Günther et al. JOURNAL OF INFECTIOUS DISEASES
- Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge
- (2011) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic
- (2010) Alexander A. Bukreyev et al. VIROLOGY
- Replication-Deficient Ebolavirus as a Vaccine Candidate
- (2009) P. Halfmann et al. JOURNAL OF VIROLOGY
- Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule
- (2009) Nancy J. Sullivan et al. NATURE REVIEWS MICROBIOLOGY
- International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials
- (2009) T. Christopher Mast et al. VACCINE
- Vaccines: Correlates of Vaccine‐Induced Immunity
- (2008) Stanley A. Plotkin CLINICAL INFECTIOUS DISEASES
- Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates
- (2008) Thomas W. Geisbert et al. PLoS Pathogens
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now